Medical Device | February 24, 2022
Study details Proof-of-Concept for Covid-19 detection via saliva screening
Methodology developed by QIMR Berghofer researchers utilizing the Agilent Cary 630 FTIR
Methodology developed by QIMR Berghofer researchers utilizing the Agilent Cary 630 FTIR
The Prescription Drug User Fee Action (PDUFA) date for adagrasib is December 14, 2022
These results will be presented on 17 February at the 2022 American Society of Clinical Oncology (ASCO) Genitourinary Cancers Symposium
According to ICMR, the upgraded OmiSure RT-PCR test for Covid-19 successfully detects all sub-types of Omicron that are currently prevalent in India
An article by a team of 12 Italian and 9 Russian scientists led by Francesco Vaia, Director of the Spallanzani Institute and Alexander Gintsburg, Director of the Gamaleya Center, has been published in medRxiv
In-house wet testing with live Omicron virus demonstrated that the Antigen test detects the Omicron variant with comparable sensitivity to other variants
The study will be published on the pre-print server, medRXiv, shortly
Recent Study by Columbia University finds Mylab’s CoviSelf can detect the Omicron variant successfully
TATA MD’s OmiSure is the only test approved by the ICMR for RT-PCR detection of the Omicron variant
Despite the challenges of pandemic disruptions, drug developers advance promising therapies for conditions, including Alzheimer's, diabetes and asthma
Subscribe To Our Newsletter & Stay Updated
